T. B, R. RK, R. AC, P. A, S. D, R. J. Effect of casirivimab-imdevimab on mild COVID-19 patients with diabetes in reducing oxygen supplementation at 28 days: an observational study. Int J Res Med Sci [Internet]. 2022 Aug. 29 [cited 2025 Sep. 27];10(9):1983-7. Available from: https://www.msjonline.org/index.php/ijrms/article/view/10966